mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.8 |